Using an unconventional approach that they designed, drug discoverers have identified compounds that hold promise for treating leishmaniasis, a parasitic infection that many consider one of the world’s most overlooked diseases.
Using an unconventional approach that they designed, drug discoverers have identified compounds that hold promise for treating leishmaniasis, a parasitic infection that many consider one of the world’s most overlooked diseases.